Babler Martin
Insider CIK 1435618 · INFI Director · NLTX Director · ZSPH Director · PRNB President, CEO, Director · PRLD Director · MPLT Director · ETNB Director · ALMS President, CEO and Chairman, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MPLT MapLight Therapeutics, Inc | A Award deriv | 2026-06-23 | 2026-06-25 | 29,804 | — | $0 | 29,804 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | A Award | 2026-06-23 | 2026-06-25 | 7,864 | — | $0 | 7,864 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2026-06-09 | 2026-06-10 | 38,000 | — | $0 | 38,000 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2026-01-26 | 2026-01-28 | 745,875 | — | $0 | 745,875 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 56,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 67,700 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-07-29 | 2025-07-31 | 662,000 | — | $0 | 662,000 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-07-29 | 2025-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-06-12 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-04-01 | 2025-04-03 | 15,650 | $6.44 | $100.8K | 106,454 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-02-18 | 2025-02-20 | 523,000 | — | $0 | 523,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 56,400 | — | $0 | 56,400 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 245,989 | — | $0 | 245,989 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 478,288 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 241,210 | — | $0 | 241,210 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 241,210 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 107,028 | — | $0 | 107,028 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 107,028 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 263,101 | — | $0 | 263,101 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 263,101 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 534,759 | — | $0 | 534,759 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 534,759 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 106,951 | — | $0 | 106,951 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 106,951 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 380,852 | — | $0 | 380,852 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 380,852 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 21,390 | — | $0 | 21,390 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 21,390 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 478,288 | — | $0 | 478,288 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 245,989 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer | 2024-07-01 | 2024-07-01 | 90,804 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2024-07-01 | 2024-07-01 | 90,804 | — | $0 | 90,804 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-06-27 | 2024-07-01 | 21,390 | — | $0 | 21,390 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 23,500 | — | $0 | 23,500 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2024-05-02 | 2024-05-03 | 67,700 | — | $0 | 67,700 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2023-06-16 | 2023-06-21 | 23,500 | — | $0 | 23,500 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2023-06-08 | 2023-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-06-17 | 2022-06-22 | 31,293 | — | $0 | 31,293 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2022-05-12 | 2022-05-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-07-19 | 2021-07-20 | 36,400 | — | $0 | 36,400 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2021-05-11 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 115,590 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 60,546 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 187,144 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 155,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 200,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 255 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 50,795 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 85,728 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 110,085 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 83,004 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | U Tender | 2020-09-28 | 2020-09-28 | 1,023 | $100.00 | $102.3K | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | U Tender | 2020-09-28 | 2020-09-28 | 18,355 | $100.00 | $1.84M | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | U Tender | 2020-09-28 | 2020-09-28 | 39,179 | $100.00 | $3.92M | 0 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2020-09-08 | 2020-09-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-06-23 | 2020-06-25 | 15,000 | — | $0 | 85,728 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-06-23 | 2020-06-25 | 11,983 | $61.82 | $740.8K | 3,312 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-06-23 | 2020-06-25 | 15,000 | $3.00 | $45.0K | 15,810 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-06-23 | 2020-06-25 | 515 | $60.32 | $31.1K | 15,295 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-06-23 | 2020-06-25 | 2,502 | $62.38 | $156.1K | 810 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2020-03-05 | 2020-03-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-03 | 2020-03-05 | 2,085 | $62.45 | $130.2K | 52,094 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-03 | 2020-03-05 | 7,183 | $63.24 | $454.3K | 44,911 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-03 | 2020-03-05 | 300 | $64.83 | $19.4K | 39,179 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-03 | 2020-03-05 | 5,432 | $64.10 | $348.2K | 39,479 | SEC↗ |
| PRNB Principia Biopharma Inc. | G Gift | 2020-02-10 | 2020-03-05 | 1,159 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | G Gift | 2020-02-10 | 2020-03-05 | 1,159 | — | $0 | 18,355 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-18 | 2019-12-19 | 1,295 | $54.28 | $70.3K | 15,696 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-18 | 2019-12-19 | 1,000 | $52.77 | $52.8K | 19,196 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-18 | 2019-12-19 | 2,205 | $53.69 | $118.4K | 16,991 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-17 | 2019-12-19 | 5,840 | $51.80 | $302.5K | 73,339 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-17 | 2019-12-19 | 11,485 | $52.86 | $607.1K | 61,854 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-17 | 2019-12-19 | 6,661 | $53.94 | $359.3K | 55,193 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-17 | 2019-12-19 | 1,014 | $54.36 | $55.1K | 54,179 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-03-01 | 2019-03-08 | 155,000 | — | $0 | 155,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 240 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 240 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 988 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 988 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 988 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 240 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 240 | — | $0 | 6,732 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 240 | — | $0 | 6,732 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 988 | — | $0 | 6,492 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 240 | — | $0 | 6,732 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 988 | — | $0 | 6,492 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 988 | — | $0 | 6,492 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 4,000 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 12,000 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer | 2015-12-17 | 2015-12-21 | 1,000 | $90.00 | $90.0K | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | A Award deriv | 2015-06-18 | 2015-06-25 | 4,000 | $55.57 | $222.3K | 4,000 | SEC↗ |
| ZSPH ZS Pharma, Inc. | A Award deriv | 2015-06-18 | 2015-06-25 | 1,000 | — | $0 | 1,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2013-06-11 | 2013-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2012-05-16 | 2012-05-18 | 6,000 | — | $0 | 6,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2012-05-16 | 2012-05-18 | 2,000 | — | $0 | 2,000 | SEC↗ |